DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Fenfluramine

Fenfluramine

  • Selective Labeling of Serotonin Receptors Byd-[3H]Lysergic Acid

    Selective Labeling of Serotonin Receptors Byd-[3H]Lysergic Acid

  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs

    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs

  • Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters

    Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters

  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss

    Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss

  • Summary of Risk Management Plan for Fintepla (Fenfluramine) This Is a Summary of the Risk Management Plan (RMP) for Fintepla

    Summary of Risk Management Plan for Fintepla (Fenfluramine) This Is a Summary of the Risk Management Plan (RMP) for Fintepla

  • Hallucinogens: an Update

    Hallucinogens: an Update

  • 212102Orig1s000

    212102Orig1s000

  • Synergistic Interactions Between Fenfluramine and Phentermine

    Synergistic Interactions Between Fenfluramine and Phentermine

  • Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

    Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

  • Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines

    Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines

  • "Ecstasy" [3,4-Methylenedioxy- Methamphetamine (MDMA)]: Serotonin Transporters Are Targets for MDMA-Induced Serotonin Release GARY RUDNICK* and STEPHEN C

  • 4-Fluoroamphetamine (4-FA) Critical Review Report Agenda Item 4.3

    4-Fluoroamphetamine (4-FA) Critical Review Report Agenda Item 4.3

  • The Substituted Amphetamines 3,4

    The Substituted Amphetamines 3,4

  • (12) United States Patent (10) Patent No.: US 8,877,802 B2 Caron Et Al

    (12) United States Patent (10) Patent No.: US 8,877,802 B2 Caron Et Al

  • Anesthetic Considerations for the New Anti-Obesity Medications L Jeffers

    Anesthetic Considerations for the New Anti-Obesity Medications L Jeffers

  • Para-Methoxymethylamphetamine (PMMA) Critical Review Report Agenda Item 5.6

    Para-Methoxymethylamphetamine (PMMA) Critical Review Report Agenda Item 5.6

  • MDMA and Fenfluramine Alter the Response of the Circadian Clock to a Serotonin Agonist in Vitro

    MDMA and Fenfluramine Alter the Response of the Circadian Clock to a Serotonin Agonist in Vitro

  • 4-Hydroxy-Tryptamine Syntheses

    4-Hydroxy-Tryptamine Syntheses

Top View
  • Nbome) Derivatives
  • Receptor Interaction Profiles of Novel N-2-Methoxybenzyl (Nbome) Derivatives
  • Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
  • PMMA) in Rats
  • Discovering the Molecular and Cellular Mechanisms Underlying Fenfluramine-Induced Cardiopulmonary Side Effects
  • English Language Searches) V
  • Fintepla, INN-Fenfluramine
  • Mass Spectral and Chromatographic Studies on a Series of Regioisomers and Isobaric Derivatives Related to Methylenedioxymethamp
  • List of Scheduling Actions, Controlled Substances And
  • Discriminative Stimulus Effects of 3,4-Methylenedioxypyrovalerone and 4-Methylmethcathinone
  • Thesis Final Edit280708
  • (2C-B): Presence in the Recreational Drug Market in Spain, Pattern of Use
  • Dose-Effect of Fenfluramine Use on the Severity of Valvular Heart Disease
  • MR. PRESIDENT and MR. SPEAKER: Your Committee on Conference on Senate Amendments to HB 2049, Submits the Following Report: the H
  • Abuse of Amphetamine, 119 Cocaine, 109 Diethylpropion, 127 Ephedrine
  • 3,4-Methylenedioxyamphetamine (MDA)
  • Localization of MDMA-Induced Brain Activity in Healthy Volunteers Using
  • Repeated Administration of the Substituted Amphetamine P


© 2024 Docslib.org    Feedback